Low Molecular Weight Heparin for Hemodialysis Anticoagulation
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Low-molecular weight heparins (LMWHs) as well as Unfractionated heparin (UFH) is used as
anticoagulation during hemodialysis (HD) therapy. In this study the investigators have
compared clinical efficacy and safety of LMWH and UFH, and their effect on lipid profile.